Company
LianBio (LIANY)
Standardized SEC financial data for LianBio — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001831283 · OTC · Pharmaceutical Preparations.
Return on equity
-37.6%
Free cash flow
-$101.0M
Current ratio
13.24×
EPS (diluted)
$-1.02
Income statement
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| R&D expense | $120.9M | $158.7M | $59.8M |
| SG&A expense | $14.0M | $36.9M | $65.6M |
| Operating income | -$134.9M |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Cash & equivalents | $43.3M | $254.4M | $383.2M | $302.4M |
| Total current assets | — | $276.7M | $399.6M | $312.8M |
Cash flow
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Operating cash flow | -$98.1M | -$164.0M | -$99.2M |
| Capital expenditures | $886K | $947K | $1.8M |
| Free cash flow | -$99.0M | -$164.9M |
Get LIANY data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LIANY/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LIANY/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"